135-87-5
基本信息
鹽酸哌羅克生
piperoxan.HC
piperoxan.HCl
933F Hydrochloride
Benodaine hydrochloride
Piperoxane hydrochloride
Piperoxan (hydrochloride)
Benzodioxane hydrochloride
2-Piperidinomethyl-1,4-benzodioxan hydrochloride
Piperoxan hydrochloride (Benodaine hydrochloride)
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS號(hào) | 包裝 | 價(jià)格 |
2024/11/08 | HY-100850 | 鹽酸哌羅克生 Piperoxan hydrochloride | 135-87-5 | 5mg | 1200元 |
2024/11/08 | HY-100850 | 鹽酸哌羅克生 Piperoxan hydrochloride | 135-87-5 | 10mM * 1mLin DMSO | 1320元 |
2024/11/08 | HY-100850 | 鹽酸哌羅克生 Piperoxan hydrochloride | 135-87-5 | 10mg | 1800元 |
常見(jiàn)問(wèn)題列表
Target | Value |
α2 adrenoceptor
() |
When the medulla is superfused with α 2 adrenoceptor antagonist Piperoxane (50 μM; 5 min) while the pons is with artificial cerebrospinal fluid (ACSF), the three inactive preparations display rhythmic phrenic bursts at a low frequency (2-4 c/min), and the phrenic burst frequency of the 12 active ones significantly increases during the last 3 min of Piperoxane applications (163±12% of the previous mean frequency). In active medullary preparations, the effects of NA applications (25 μM; 5 min) are compared when the preparations sre superfused either by ACSF (n=8) or by the α2 adrenoceptor antagonist Piperoxane (50 μM; PIP-ACSF; n=5). NA applications either alone (NA-ACSF) or with Piperoxane (PIP-ACSF+NA) significantly increases the phrenic burst frequency. However, the blockage of the medullary α2 adrenoceptors by Piperoxane potentiates a phrenic burst frequency increase: during the fifth minute of NA applications, the phrenic burst frequency reached 171±11% of the mean control value when ACSF is applied alone and 234±21% of the mean control value when PIP-ACSF is applied in control condition.